Methyltransferase‐Like Protein 14 Attenuates Mitochondrial Antiviral Signaling Protein Expression to Negatively Regulate Antiviral Immunity via N6‐methyladenosine Modification

Abstract Mitochondrial antiviral signaling (MAVS) protein is the core signaling adaptor in the RNA signaling pathway. Thus, appropriate regulation of MAVS expression is essential for antiviral immunity against RNA virus infection. However, the regulation of MAVS expression at the mRNA level especial...

Full description

Bibliographic Details
Main Authors: Fei Qin, Baoshan Cai, Jian Zhao, Lei Zhang, Yi Zheng, Bingyu Liu, Chengjiang Gao
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202100606
_version_ 1818602755206414336
author Fei Qin
Baoshan Cai
Jian Zhao
Lei Zhang
Yi Zheng
Bingyu Liu
Chengjiang Gao
author_facet Fei Qin
Baoshan Cai
Jian Zhao
Lei Zhang
Yi Zheng
Bingyu Liu
Chengjiang Gao
author_sort Fei Qin
collection DOAJ
description Abstract Mitochondrial antiviral signaling (MAVS) protein is the core signaling adaptor in the RNA signaling pathway. Thus, appropriate regulation of MAVS expression is essential for antiviral immunity against RNA virus infection. However, the regulation of MAVS expression at the mRNA level especially at the post transcriptional level is not well‐defined. Here, it is reported that the MAVS mRNA undergoes N6‐methyladenosine (m6A) modification through methyltransferase‐like protein 14 (METTL14), which leads to a fast turnover of MAVS mRNA. Knockdown or deficiency of METTL14 increases MAVS mRNA stability, and downstream phosphorylation of TBK1/IRF3 and interferon‐β production in response to RNA viruses. Compared to wild‐type mice, heterozygotes Mettl14+/− mice better tolerate RNA virus infection. The authors' findings unveil a novel mechanism to regulate the stability of MAVS transcripts post‐transcriptionally through m6A modification.
first_indexed 2024-12-16T13:12:19Z
format Article
id doaj.art-620e0b1815564dbe96cbfdd3817e5f73
institution Directory Open Access Journal
issn 2198-3844
language English
last_indexed 2024-12-16T13:12:19Z
publishDate 2021-08-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj.art-620e0b1815564dbe96cbfdd3817e5f732022-12-21T22:30:35ZengWileyAdvanced Science2198-38442021-08-01815n/an/a10.1002/advs.202100606Methyltransferase‐Like Protein 14 Attenuates Mitochondrial Antiviral Signaling Protein Expression to Negatively Regulate Antiviral Immunity via N6‐methyladenosine ModificationFei Qin0Baoshan Cai1Jian Zhao2Lei Zhang3Yi Zheng4Bingyu Liu5Chengjiang Gao6Key Laboratory of Infection and Immunity of Shandong Province and Department of Immunology School of Biomedical Sciences Shandong University Jinan Shandong 250012 P. R. ChinaKey Laboratory of Infection and Immunity of Shandong Province and Department of Immunology School of Biomedical Sciences Shandong University Jinan Shandong 250012 P. R. ChinaKey Laboratory of Infection and Immunity of Shandong Province and Department of Immunology School of Biomedical Sciences Shandong University Jinan Shandong 250012 P. R. ChinaKey Laboratory of Infection and Immunity of Shandong Province and Department of Immunology School of Biomedical Sciences Shandong University Jinan Shandong 250012 P. R. ChinaKey Laboratory of Infection and Immunity of Shandong Province and Department of Immunology School of Biomedical Sciences Shandong University Jinan Shandong 250012 P. R. ChinaKey Laboratory of Infection and Immunity of Shandong Province and Department of Immunology School of Biomedical Sciences Shandong University Jinan Shandong 250012 P. R. ChinaKey Laboratory of Infection and Immunity of Shandong Province and Department of Immunology School of Biomedical Sciences Shandong University Jinan Shandong 250012 P. R. ChinaAbstract Mitochondrial antiviral signaling (MAVS) protein is the core signaling adaptor in the RNA signaling pathway. Thus, appropriate regulation of MAVS expression is essential for antiviral immunity against RNA virus infection. However, the regulation of MAVS expression at the mRNA level especially at the post transcriptional level is not well‐defined. Here, it is reported that the MAVS mRNA undergoes N6‐methyladenosine (m6A) modification through methyltransferase‐like protein 14 (METTL14), which leads to a fast turnover of MAVS mRNA. Knockdown or deficiency of METTL14 increases MAVS mRNA stability, and downstream phosphorylation of TBK1/IRF3 and interferon‐β production in response to RNA viruses. Compared to wild‐type mice, heterozygotes Mettl14+/− mice better tolerate RNA virus infection. The authors' findings unveil a novel mechanism to regulate the stability of MAVS transcripts post‐transcriptionally through m6A modification.https://doi.org/10.1002/advs.202100606antiviral immunityN6‐methyladenosine modificationmethyltransferase‐like protein 14mitochondrial antiviral signaling proteinmRNA stability
spellingShingle Fei Qin
Baoshan Cai
Jian Zhao
Lei Zhang
Yi Zheng
Bingyu Liu
Chengjiang Gao
Methyltransferase‐Like Protein 14 Attenuates Mitochondrial Antiviral Signaling Protein Expression to Negatively Regulate Antiviral Immunity via N6‐methyladenosine Modification
Advanced Science
antiviral immunity
N6‐methyladenosine modification
methyltransferase‐like protein 14
mitochondrial antiviral signaling protein
mRNA stability
title Methyltransferase‐Like Protein 14 Attenuates Mitochondrial Antiviral Signaling Protein Expression to Negatively Regulate Antiviral Immunity via N6‐methyladenosine Modification
title_full Methyltransferase‐Like Protein 14 Attenuates Mitochondrial Antiviral Signaling Protein Expression to Negatively Regulate Antiviral Immunity via N6‐methyladenosine Modification
title_fullStr Methyltransferase‐Like Protein 14 Attenuates Mitochondrial Antiviral Signaling Protein Expression to Negatively Regulate Antiviral Immunity via N6‐methyladenosine Modification
title_full_unstemmed Methyltransferase‐Like Protein 14 Attenuates Mitochondrial Antiviral Signaling Protein Expression to Negatively Regulate Antiviral Immunity via N6‐methyladenosine Modification
title_short Methyltransferase‐Like Protein 14 Attenuates Mitochondrial Antiviral Signaling Protein Expression to Negatively Regulate Antiviral Immunity via N6‐methyladenosine Modification
title_sort methyltransferase like protein 14 attenuates mitochondrial antiviral signaling protein expression to negatively regulate antiviral immunity via n6 methyladenosine modification
topic antiviral immunity
N6‐methyladenosine modification
methyltransferase‐like protein 14
mitochondrial antiviral signaling protein
mRNA stability
url https://doi.org/10.1002/advs.202100606
work_keys_str_mv AT feiqin methyltransferaselikeprotein14attenuatesmitochondrialantiviralsignalingproteinexpressiontonegativelyregulateantiviralimmunityvian6methyladenosinemodification
AT baoshancai methyltransferaselikeprotein14attenuatesmitochondrialantiviralsignalingproteinexpressiontonegativelyregulateantiviralimmunityvian6methyladenosinemodification
AT jianzhao methyltransferaselikeprotein14attenuatesmitochondrialantiviralsignalingproteinexpressiontonegativelyregulateantiviralimmunityvian6methyladenosinemodification
AT leizhang methyltransferaselikeprotein14attenuatesmitochondrialantiviralsignalingproteinexpressiontonegativelyregulateantiviralimmunityvian6methyladenosinemodification
AT yizheng methyltransferaselikeprotein14attenuatesmitochondrialantiviralsignalingproteinexpressiontonegativelyregulateantiviralimmunityvian6methyladenosinemodification
AT bingyuliu methyltransferaselikeprotein14attenuatesmitochondrialantiviralsignalingproteinexpressiontonegativelyregulateantiviralimmunityvian6methyladenosinemodification
AT chengjianggao methyltransferaselikeprotein14attenuatesmitochondrialantiviralsignalingproteinexpressiontonegativelyregulateantiviralimmunityvian6methyladenosinemodification